Unknown

Dataset Information

0

Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?


ABSTRACT: OBJECTIVES:To assess complete gross resection (CGR) rates and survival outcomes in patients with advanced ovarian cancer who underwent primary debulking surgery (PDS) during a 13-year period in which specific changes to surgical paradigm were implemented. METHODS:We identified all patients with stage IIIB-IV high-grade ovarian carcinoma who underwent PDS at our institution, with the intent of maximal cytoreduction, from 1/2001-12/2013. Patients were categorized by year of PDS based on the implementation of surgical changes to our approach to ovarian cancer debulking (Group 1, 2001-2005; Group 2, 2006-2009; Group 3, 2010-2013). RESULTS:Among 978 patients, 78% had stage IIIC disease and 89% had disease of serous histology. Carcinomatosis was found in 81%, and 60% had bulky upper abdominal disease (UAD). Compared to Group 1, those who underwent PDS during the latter 2 time periods had higher ASA scores (p?

SUBMITTER: Tseng JH 

PROVIDER: S-EPMC6247423 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?

Tseng Jill H JH   Cowan Renee A RA   Zhou Qin Q   Iasonos Alexia A   Byrne Maureen M   Polcino Tracy T   Polen-De Clarissa C   Gardner Ginger J GJ   Sonoda Yukio Y   Zivanovic Oliver O   Abu-Rustum Nadeem R NR   Long Roche Kara K   Chi Dennis S DS  

Gynecologic oncology 20180817 1


<h4>Objectives</h4>To assess complete gross resection (CGR) rates and survival outcomes in patients with advanced ovarian cancer who underwent primary debulking surgery (PDS) during a 13-year period in which specific changes to surgical paradigm were implemented.<h4>Methods</h4>We identified all patients with stage IIIB-IV high-grade ovarian carcinoma who underwent PDS at our institution, with the intent of maximal cytoreduction, from 1/2001-12/2013. Patients were categorized by year of PDS base  ...[more]

Similar Datasets

| S-EPMC9878303 | biostudies-literature
| S-EPMC6149661 | biostudies-literature
| S-EPMC6028180 | biostudies-literature
| S-EPMC5342355 | biostudies-literature
| S-EPMC6536958 | biostudies-literature
| S-EPMC8440068 | biostudies-literature
| S-EPMC9248270 | biostudies-literature
| S-EPMC5339626 | biostudies-literature
| S-EPMC6078894 | biostudies-other
| S-EPMC6406820 | biostudies-literature